CSF3 and small cell lung carcinoma: Clinically, findings are context-dependent: in extensive-stage small-cell lung cancer, a recent retrospective analysis suggested that concomitant G-CSF could attenuate chemo-immunotherapy efficacy, whereas another cohort reported no significant impact on outcomes.